Commentary
This article discusses a workshop held at the 18th Annual Conference of the Pharmaceutical Contract Management Group (PCMG) in Krakow on 9th September 2022, which asked over 200 delegates what the clinical trial landscape would look like in 2050.
Case Report
This case report discusses a patient with tuberculosis who experienced drug-induced liver injury, and the initiation of treatment with silymarin resulted in a significant hepatoprotective effects as shown by decreased liver enzyme activity.
Original Research
This article reports findings on consumption behaviour, reason for intake and frequency of intake as well as consumer experience, satisfaction and characteristics of Supradyn Recharge or Supradyn Magnesium+Potassium.
Case Report
This case report discusses daily treatment with silymarin and highlights moderate efficacy and a good safety profile in the management of non-alcoholic steatohepatitis (NASH) and liver function with no side-effects, supporting silymarin as a promising supplemental intervention that can normalize liver activity in non-alcoholic fatty liver disease and NASH.
Original Research
This article analyzes the data collected from the T-Coach patient support programme and evaluates the effect of the programme in terms of treatment satisfaction, adherence and effect on disease knowledge. 6-month results are present here.
